At the immunohistochemical level, fibrolamellar carcinoma is characterized by cytokeratin 71, 2 and CD68 co-expression.3 These immunostains are useful to support the diagnosis of fibrolamellar carcinoma. Here, KRT71 is linked to fibrolamellar hepatocellular carcinoma.